A CASE OF SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS – DIFFICULTIES AND POSSIBILITIES IN TREATMENT
https://doi.org/10.17650/1818-8338-2013-3-4-62-66
Abstract
We present a case of severe systemic lupus erythematosus (SLE) in 24-year-old woman. The specific features of the disease in this case were high disease activity, leucopenia, remitting ulcerative necrotizing skin vasculitis, secondary infectious complications. There was no other organic and haematological disorders typical for SLE, except leucopenia. Adequate treatment with high – dosage glucocorticoids in oral and glucocorticoid pulse-therapy, intravenous antibiotics, intravenous immunoglobulin, vasoactive therapy was successful and lead to decrease of inflammatory process.
About the Authors
O. L. Aleksandrova
V.I. Razumovsky Saratov State Medical University, Ministry of Health of Russia
Russian Federation
Department of Hospital Therapy, Faculty of Therapeutics
Russian Federation
Department of Hospital Therapy, Faculty of Therapeutics
I. A. Butenko
V.I. Razumovsky Saratov State Medical University, Ministry of Health of Russia
Russian Federation
Department of Hospital Therapy, Faculty of Therapeutics
Russian Federation
Department of Hospital Therapy, Faculty of Therapeutics
N. M. Nikitina
V.I. Razumovsky Saratov State Medical University, Ministry of Health of Russia
Russian Federation
Department of Hospital Therapy, Faculty of Therapeutics
Russian Federation
Department of Hospital Therapy, Faculty of Therapeutics
I. F. Nam
V.I. Razumovsky Saratov State Medical University, Ministry of Health of Russia
Russian Federation
Department of Hospital Therapy, Faculty of Therapeutics
Russian Federation
Department of Hospital Therapy, Faculty of Therapeutics
A. P. Rebrov
V.I. Razumovsky Saratov State Medical University, Ministry of Health of Russia
Russian Federation
Department of Hospital Therapy, Faculty of Therapeutics
Russian Federation
Department of Hospital Therapy, Faculty of Therapeutics
References
1. Ревматология: клинические рекомендации. Под ред. Е. Л. Насонова. 2-е изд., испр. и доп. М.: ГЭОТАР-Медиа, 2011. 752 с.
2. Сигидин Я. А., Гусева Н. Г., Иванова М. М. Диффузные болезни соединительной ткани: Руководство для врачей. М.: Медицина, 2004. С. 241–53.
3. Тарасова И. А., Иванова М. М. Исходы и прогноз при системной красной волчанке. Науч-практ ревматол 2003;(2):53–8.
4. Иванова М. М., Соловьев С. К. Достижения и перспективы лечения системной красной волчанки. Тер архив 2009;81(12):44–7.
5. Лучихина Е. Л., Каратеев Д. Е., Соловьев С. К., Иванова М. М. Структура летальных исходов при системной красной волчанке по данным Института ревматологии РАМН. Рос ревматол 1998;(3):2–9.
6. Bujan S., Odri-Ros J., Paredes J. et al. Contribution of the initial features of systemic lupus erythematosus to the clinical evalution and survival of a cohort of Mediterranean patients. Ann Rheum Dis 2003;62(9):859–65.
7. Petri M. Infection in systemic lupus erythematosus. Rheum Dis Clin North Am 1998;24(2):423–56.
8. Клюквина Н. Г., Насонов Е. Л. Иммуносупрессивная терапия СКВ: достоинства, недостатки и возможности совершенствования. Рус мед журн 2007;15(8):635–41.
9. Кучма Г. Б., Бугрова О. В. Изменение уровня лейкоцитов и лейкоцитарной формулы у больных системной красной волчанкой в зависимости от течения заболевания и характера проводимой терапии. Вестн ВолгГМУ 2010;(2):100–4.
10. Ward M. M., Pyun E., Studenski S. Mortality risks associated with specific clinical manifestation of systemic lupus erythematosus. Arch Intern Med 1996;156(12):1337–44.
11. Kang I., Park S. H. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol 2003;15(5):528–34.
12. Le Moing V., Leport C. Infections and lupus. Rev Prat 1998;48(6):637–42.
13. Kamen D. L. How can we reduce the risk of serious infection for patients with systemic lupus erythematosus? Arthritis Res Ther 2009;11(5):129.
14. Gherardi R. K., Coquet M., Cherin P. et al. Macrophagic myofasciitis lesions assess longterm persistence of vaccine-derived aluminium hydroxide in muscle. Brain 2001;124(Pt 9):1821–31.
Review
For citations:
Aleksandrova O.L., Butenko I.A., Nikitina N.M., Nam I.F., Rebrov A.P. A CASE OF SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS – DIFFICULTIES AND POSSIBILITIES IN TREATMENT. The Clinician. 2013;7(3-4):62-66. (In Russ.) https://doi.org/10.17650/1818-8338-2013-3-4-62-66
Views:
1063
Email this article 